electroCore (ECOR) Cash & Equivalents Growth (1y) (2018 - 2026)
electroCore (ECOR) Cash & Equivalents Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | 4.15% |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | 24.05% |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | -7.50% |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | 100.41% |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | -22.13% |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | 23.57% |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | -7.71% |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 20.15% |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | 156.03% |
| 10 | electroCore | 85,948.80 | -8.79 Mn | 8.36 Mn | 29.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.73% |
| Dec 31, 2025 | 90.14% |
| Sep 30, 2025 | 59.40% |
| Jun 30, 2025 | -67.26% |
| Mar 31, 2025 | -51.88% |
| Dec 31, 2024 | -64.19% |
| Sep 30, 2024 | -63.38% |
| Jun 30, 2024 | 22.03% |
| Mar 31, 2024 | -34.09% |
| Dec 31, 2023 | -41.67% |
| Sep 30, 2023 | -37.81% |
| Jun 30, 2023 | -67.94% |
| Mar 31, 2023 | -60.15% |
| Dec 31, 2022 | -48.94% |
| Sep 30, 2022 | -43.03% |
| Jun 30, 2022 | 79.13% |
| Mar 31, 2022 | 229.66% |
| Dec 31, 2021 | 717.76% |
| Sep 30, 2021 | 891.40% |
| Jun 30, 2021 | -1.10% |